Jorn Assmann

Jorn Assmann is a researcher in the Department of Immunology at Erasmus MC, Rotterdam. His work focuses on molecular and functional aspects of lymphocyte biology, particularly in the context of chronic lymphocytic leukemia (CLL) and T-cell large granular lymphocyte leukemia. He employs advanced techniques such as high-throughput proteomics and next-generation sequencing to identify biomarkers and understand immune dysregulation.

His research interests include:

• T-cell receptor repertoire dynamics
• Minimal residual disease detection in CLL
• Proteomic biomarker discovery
• STAT3 signaling in lymphoproliferative disorders
• Immune cell signaling and regulation
• Molecular mechanisms of T-cell leukemias

The recent publications show a strong trend toward integrating proteomic and genomic data to improve prognostic stratification in hematological malignancies. His work frequently involves collaborative, multi-center studies and has been published in high-impact journals such as Blood and HemaSphere.

Jorn Assmann has not received any explicitly mentioned scientific awards in the provided text.

He has contributed significantly to research in immunology and hematological cancers, particularly through biomarker discovery and functional characterization of lymphocyte disorders. While no formal advising roles are mentioned, his involvement in doctoral research suggests mentorship within a collaborative team environment. His research is supported through institutional affiliations and collaborative networks at Erasmus MC.

His work is embedded within the immunology research group at Erasmus MC, which focuses on translational immunology, lymphocyte signaling, and molecular diagnostics in hematological diseases.